Literature DB >> 21457516

Selective digestive decontamination is superior to selective oropharyngeal decontamination.

Luciano Silvestri, Nia Taylor, Durk F Zandstra, Hendrick K F van Saene.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21457516      PMCID: PMC3219328          DOI: 10.1186/cc10068

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

We are interested in the debate on the efficacy and safety of selective digestive decontamination (SDD) and selective oropharyngeal decontamination (SOD) raised by Schultz and Haas in their review [1]. The authors concluded that 'SDD and SOD are equally effective with respect to the prevention of mortality' [1]. This statement is based on the results of a Dutch randomized controlled trial [2], which was the first to demonstrate a survival benefit of SOD. However, the mortality reduction was higher, albeit not significantly, in the SDD group than in the SOD group. Additionally, a recent meta-analysis, including nine SOD randomized controlled trials and 4,733 patients, failed to show any significant mortality reduction (odds ratio (OR) = 0.93; 95% confidence interval (CI) = 0.81 to 1.07) [3]. In contrast, there is robust evidence indicating that SDD including parenteral and enteral antimicrobials significantly reduces mortality [4]. The authors wrote that 'whether SDD or SOD are favorable with regard to development of antibiotic resistance is yet unknown' [1]. The Dutch randomized controlled trial, however, showed that patients with aerobic Gram-negative bacilli in rectal swabs resistant to the marker antibiotics numbered less with SDD than with SOD [2]. Additionally, bacteremia due to highly resistant pathogens was significantly reduced by SDD compared with SOD (OR = 0.37, 95% CI = 0.16 to 0.85), and lower respiratory tract colonization due to highly resistant pathogens was lower with SDD (OR = 0.58, 95% CI = 0.43 to 0.78) than with SOD (OR = 0.65, 95% CI = 0.49 to 0.87) compared with standard care [5]. We believe that SDD is superior to SOD in terms of both mortality reduction and emergence of resistance.

Abbreviations

CI: confidence interval; OR: odds ratio; SDD: selective digestive decontamination; SOD: selective oropharyngeal decontamination.

Competing interests

The authors declare that they have no competing interests.
  4 in total

1.  SDD, SOD, or oropharyngeal chlorhexidine to prevent pneumonia and to reduce mortality in ventilated patients: which manoeuvre is evidence-based?

Authors:  Luciano Silvestri; Hendrick K F van Saene; Durk F Zandstra; Marino Viviani; Dario Gregori
Journal:  Intensive Care Med       Date:  2010-03-18       Impact factor: 17.440

Review 2.  Survival benefit of the full selective digestive decontamination regimen.

Authors:  Luciano Silvestri; Hendrick K F van Saene; Ian Weir; Antonino Gullo
Journal:  J Crit Care       Date:  2009-02-12       Impact factor: 3.425

3.  Decontamination of the digestive tract and oropharynx in ICU patients.

Authors:  A M G A de Smet; J A J W Kluytmans; B S Cooper; E M Mascini; R F J Benus; T S van der Werf; J G van der Hoeven; P Pickkers; D Bogaers-Hofman; N J M van der Meer; A T Bernards; E J Kuijper; J C A Joore; M A Leverstein-van Hall; A J G H Bindels; A R Jansz; R M J Wesselink; B M de Jongh; P J W Dennesen; G J van Asselt; L F te Velde; I H M E Frenay; K Kaasjager; F H Bosch; M van Iterson; S F T Thijsen; G H Kluge; W Pauw; J W de Vries; J A Kaan; J P Arends; L P H J Aarts; P D J Sturm; H I J Harinck; A Voss; E V Uijtendaal; H E M Blok; E S Thieme Groen; M E Pouw; C J Kalkman; M J M Bonten
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

Review 4.  Antibiotics or probiotics as preventive measures against ventilator-associated pneumonia: a literature review.

Authors:  Marcus J Schultz; Lenneke E Haas
Journal:  Crit Care       Date:  2011-01-13       Impact factor: 9.097

  4 in total
  1 in total

1.  The rising problem of antimicrobial resistance in the intensive care unit.

Authors:  Nele Brusselaers; Dirk Vogelaers; Stijn Blot
Journal:  Ann Intensive Care       Date:  2011-11-23       Impact factor: 6.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.